Stockscreener 앱 받기
48.57
0.52%
0.25
시간 외 거래:
48.57
전일 마감가:
$48.32
열려 있는:
$48.455
하루 거래량:
1.62M
Relative Volume:
0.81
시가총액:
$10.01B
수익:
$2.07B
순이익/손실:
$405.37M
주가수익비율:
24.89
EPS:
1.9513
순현금흐름:
$472.50M
1주 성능:
-3.65%
1개월 성능:
-12.41%
6개월 성능:
-1.28%
1년 성능:
+25.93%
1일 변동 폭
$47.96
$48.72
1주일 범위
$47.96
$49.80
52주 변동 폭
$37.74
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
48.57 | 9.96B | 2.07B | 405.37M | 472.50M | 1.9513 |
|
TMO
Thermo Fisher Scientific Inc
|
510.93 | 193.53B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.50 | 149.33B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
635.66 | 50.36B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
122.90 | 35.73B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
333.33 | 32.24B | 3.17B | 642.63M | 539.81M | 10.77 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-22 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Jefferies Maintains Qiagen NV(QGEN.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛
MACD Signal: Can Qiagen NV sustain its profitabilityQuarterly Trade Review & Trade Opportunity Analysis Reports - baoquankhu1.vn
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - Defense World
Trend Recap: Should I average down on Qiagen NV stock2025 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
Qiagen discloses executive share-based compensation transaction - The Globe and Mail
BlackRock Discloses 10.68% Capital Interest and 11.8% Voting Stake in Qiagen - The Globe and Mail
Qiagen N.V.: Why This Quiet Biotech Stock Just Got Loud for US Investors - AD HOC NEWS
Traders Purchase High Volume of Put Options on Qiagen (NYSE:QGEN) - MarketBeat
New Evercode v4 lets labs profile 5M cells, recover 75% more - Stock Titan
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $50 - 富途牛牛
Statutory Profit Doesn't Reflect How Good Qiagen's (NYSE:QGEN) Earnings Are - Yahoo Finance
Qiagen NV (QGEN) Shares Down 3.25% on Feb 17 - GuruFocus
Death Cross: What hedge funds are buying Galaxy Payroll Group Limited2025 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn
How Qiagen N.V. (QIA) stock expands through international marketsJuly 2025 Update & Accurate Intraday Trade Tips - mfd.ru
Is Qiagen N.V. backed by strong institutional buyingJuly 2025 Review & Daily Stock Momentum Reports - mfd.ru
What are Qiagen N.V.’s recent SEC filings showingSwing Trade & Long-Term Growth Stock Strategies - mfd.ru
Does Qiagen N.V. align with a passive investing strategyPortfolio Update Report & Daily Entry Point Alerts - mfd.ru
Can Qiagen N.V. ride the EV wave2025 Fundamental Recap & Daily Chart Pattern Signals - mfd.ru
What’s next for Qiagen N.V. stockJuly 2025 Summary & Accurate Intraday Trading Signals - mfd.ru
Can Qiagen N.V. sustain its profitabilityIPO Watch & Risk Controlled Daily Trade Plans - mfd.ru
Qiagen’s Greener Lab Automation Push And What It Could Mean For Growth - Sahm
UBS Maintains Qiagen NV(QGEN.US) With Hold Rating, Announces Target Price $52 - 富途牛牛
Qiagen N.V. (NYSE:QGEN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock? - 富途牛牛
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - MarketBeat
What is Qiagen N.V. s P E ratio telling usGDP Growth & Free Fast Entry Momentum Trade Alerts - mfd.ru
Is Qiagen N.V. stock a top pick in earnings seasonJuly 2025 Decliners & Technical Buy Zone Confirmations - mfd.ru
Goldman Sachs Discloses 2.87% Stake in QIAGEN via AFM Filing - The Globe and Mail
QIAGEN NV : Buy rating from Berenberg - marketscreener.com
QIAGEN Is Unleashing a Powerful Product Expansion Strategy — And It’s Reshaping Growth! - Smartkarma
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Why is Qiagen N.V. stock going upGap Up & Scalable Portfolio Growth Methods - mfd.ru
Goldman Sachs Discloses 3.06% Stake in Qiagen via AFM Filing - TipRanks
UBS Adjusts QIAGEN Price Target to $52 From $50, Maintains Neutral Rating - marketscreener.com
Qiagen N.V. $QGEN Shares Sold by Nuance Investments LLC - MarketBeat
Qiagen N : Fourth Quarter 2025 Transcript - marketscreener.com
Entry Recap: Is Qiagen NV backed by strong institutional buyingWeekly Investment Report & Expert Verified Movement Alerts - baoquankhu1.vn
Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches - MSN
Qiagen Tops 2025 Guidance and Sets Ambitious 2026 Growth Targets - The Globe and Mail
Qiagen Q4 Earnings Call Highlights - MarketBeat
Qiagen N.V. (NYSE:QGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Qiagen (QGEN) PT Raised by JP Morgan Amid Overweight Rating | QG - GuruFocus
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $60.00 - MarketBeat
Stifel raises Qiagen stock price target to $50 on growth outlook By Investing.com - Investing.com South Africa
Stifel raises Qiagen stock price target to $50 on growth outlook - Investing.com Nigeria
Citigroup Cuts Qiagen (NYSE:QGEN) Price Target to $55.00 - MarketBeat
QGEN Analyst Rating: Citigroup Maintains Neutral, Lowers Price T - GuruFocus
Qiagen (QGEN): Stifel Raises Price Target to $50, Maintains Hold - GuruFocus
Qiagen NV (QGEN) PT Raised to $50 at Stifel - StreetInsider
Qiagen: 2025 ended positively, entering 2026 with confidence - marketscreener.com
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.07%
자본화:
|
볼륨(24시간):